ZBH

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Zimmer Biomet Holdings Inc

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
CEO
Bryan Hanson
Employees
20000
Headquarters

345 E Main St
Warsaw, Indiana 46580-2746
Phone: 15742676131
www.zimmerbiomet.com

News

ZBH stock upgraded at Wells Fargo on ortho trends and realistic outlook (NYSE:ZBH)
Nov 23, 2022 13:37pm

Wells Fargo upgraded the MedTech company Zimmer Biomet Holdings (ZBH) to Equal Weight from Underweight on Wednesday, noting, among other things, improving market trends for orthopedics…


Source:Seeking Alpha
AI-based Surgical Robots Global Market Report 2022: Ukraine-Russia War Impact
Nov 23, 2022 13:00pm

NEW YORK, Nov. 23, 2022 /PRNewswire/ -- Major players in the ai-based surgical robots market are Accuray Incorporated, Intuitive Surgical Inc, Medtronic plc, Medrobotics Corporation, Zimmer Biomet, Stereotaxis Inc, TransEnterix Inc , Stryker Corporation, Activ Surgical Inc, Titan Medical…


Source:PR Newswire
Wells Fargo Upgrades Zimmer Biomet to Equal Weight
Nov 23, 2022 10:21am

https://www.investing.com/news/pro/wells-fargo-upgrades-zimmer-biomet-to-equal-weight-432SI-2950610


Source:Investing.com
Zimmer Biomet to Present at the 34th Annual Piper Sandler Healthcare Conference
Nov 21, 2022 13:00pm

WARSAW, Ind., Nov. 21, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Executive Management Team will present at the 34th Annual Piper Sandler Healthcare Conference on Thursday, December 1,…


Source:PR Newswire
Zimmer''s Persona OsseoTi system for cementless knee replacement gets FDA nod
Nov 21, 2022 12:51pm

The U.S. Food and Drug Administration ((FDA)) granted 510(k) clearance to Zimmer Biomet''s (ZBH) Persona OsseoTi Keel Tibia for cementless knee replacement.The device is an addition to…


Source:Seeking Alpha
Zimmer Biomet Expands Persona® Knee System Portfolio with FDA Clearance of Persona® OsseoTi® Keel Tibia for Cementless Knee Replacement
Nov 21, 2022 12:00pm

-- New Porous Iteration of Anatomic Keeled Tibia Designed to Deliver Stable Initial and Biological Fixation Together with the Clinically Proven Benefits of the Persona Knee System -- WARSAW, Ind., Nov. 21, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global…


Source:PR Newswire
Zimmer Biomet Holdings opens its first Romanian branch in Sema Parc - Business Review
Nov 11, 2022 10:24am

Offices - River Development, the developer of Sema Parc and The Light projects, announces the lease of office space to Zimmer Biomet Romania in the Paris office


Source:Business Review
Zimmer Biomet Holdings opens its first Romanian branch in Sema Parc
Nov 11, 2022 10:21am

River Development, the developer of Sema Parc and The Light projects, announces the lease of office space to Zimmer Biomet Romania in the Paris office building in Sema Parc. Zimmer Biomet Holdings is opening its first branch in Romania and is investing more than €3.5 million in our country in 2023. The investment will go towards logistical expenses (new office, warehouse, etc.), building the local team and securing equipment stock. The company will move from distributor representation to direct representation, and this change will mean expanding its product portfolio, medical education offering and introducing a number of integrated digital and robotic technologies to the Romanian market. With the opening of the new office in Sema Parc, Romanian patients will have access to Zimmer Biomet’s latest and most modern products, a wider range of solutions for sports medicine, joint and extremity reconstruction, as well as the company’s digital and robotic technologies. The ZBEdge range combines integrated digital technologies, implants, robotics and monitoring services, providing a unique medical platform in orthopaedics.


Source:The Romania Journal
ANCHOR CAPITAL ADVISORS LLC Buys 3, Sells 2 in 3rd Quarter
Nov 10, 2022 00:00am

Related Stocks: TT , ARE , BURL , ZBH , LKQ ,


Source:GuruFocus
Zimmer Biomet Reports Positive Data From Mymobility Clinical Study
Nov 05, 2022 13:34pm

WASHINGTON (dpa-AFX) - Zimmer Biomet Holdings Inc. (ZBH) said one-year data from mymobility clinical study showed that using mymobility with Apple Watch following primary knee arthroplasty, common…


Source:Finanz Nachrichten
Zimmer Biomet Holdings, Inc. (ZBH) Q3 2022 Earnings Call Transcript
Nov 02, 2022 17:39pm

Zimmer Biomet Holdings, Inc. (NYSE:NYSE:ZBH) Q3 2022 Earnings Conference Call November 02, 2022 08:30 AM ET Company Participants Keri Mattox - Senior Vice President, Chief Communications…


Source:Seeking Alpha
Weak Fundamental Momentum Drags Zimmer Biomet Holdings Inc. (ZBH) Upper
Nov 02, 2022 17:00pm

Zimmer Biomet Holdings Inc. (NYSE:ZBH) has a beta value of 1.08 and has seen 0.73 million shares traded in the recent trading session. The company, currently valued at $23.07B, closed the recent trade at $112.62 per share which meant it gained $0.78 on the day or 0.70% during that session. The ZBH stock price is … Weak Fundamental Momentum Drags Zimmer Biomet Holdings Inc. (ZBH) Upper Read More »


Source:Marketing Sentinel
Zimmer Biomet PT Raised to $128 at Evercore ISI
Nov 02, 2022 14:53pm

https://www.investing.com/news/pro/zimmer-biomet-pt-raised-to-128-at-evercore-isi-432SI-2929635


Source:Investing.com
Zimmer Biomet Earnings, Revenue Beat in Q3 By Investing.com
Nov 02, 2022 11:17am

Zimmer Biomet Earnings, Revenue Beat in Q3


Source:Investing.com
Zimmer Biomet Holdings Inc. Q3 Income Advances
Nov 02, 2022 10:58am

WASHINGTON (dpa-AFX) - Zimmer Biomet Holdings Inc. (ZBH) announced a profit for its third quarter that increased from the same period last yearThe company''s earnings came in at $194.0 million, or …


Source:Finanz Nachrichten
Zimmer Biomet Holdings Tops Q3 EPS by 2c; Bumps FY Outlook Higher By Investing.com
Nov 02, 2022 10:47am

Zimmer Biomet Holdings Tops Q3 EPS by 2c; Bumps FY Outlook Higher


Source:Investing.com
Recap: Zimmer Biomet Q3 Earnings
Nov 02, 2022 10:46am

Zimmer Biomet Holdings (NYSE: ZBH ) reported its Q3 earnings results on Wednesday, November 2, 2022 at 06:30 AM. Here''s what investors need to know about the announcement. Earnings Zimmer Biomet Holdings beat estimated earnings by 1.28%, reporting an EPS of $1.58 … Full story available on Benzinga.com


Source:Benzinga
Zimmer Biomet reports Q3 earnings beat; raises FY22 guidance range
Nov 02, 2022 10:35am

Zimmer Biomet press release (ZBH): Q3 Non-GAAP EPS of $1.58 beats by $0.02.Revenue of $1.67B (-1.2% Y/Y) beats by $30M.Company updates 2022 financial guidance, raising range for…


Source:Seeking Alpha
Zimmer Biomet Q3 2022 Earnings Preview
Nov 01, 2022 17:26pm

Zimmer Biomet (ZBH) is scheduled to announce Q3 earnings results on Wednesday, November 2nd, before market open.The consensus EPS Estimate is $1.56 (-13.8% Y/Y) and the consensus Revenue…


Source:Seeking Alpha
DELTA FINANCIAL ADVISORS LLC Buys 2, Sells 3 in 3rd Quarter
Oct 28, 2022 03:00am

Related Stocks: PG , ZBH , NVS , XOM , AMED ,


Source:GuruFocus
Zimmer Biomet Holdings – Consensus Indicates Potential 16.7% Upside
Oct 23, 2022 09:14am

Zimmer Biomet Holdings with ticker code (ZBH) now have 22 analysts in total covering the stock. The consensus rating is ''Hold''. The range between the high target price and low target price is between 145 and 95 with a mean TP of 124.05. With the stocks previous close at 106.33 this would imply there is a potential upside of 16.7%. The 50 day moving average now sits at 110.09 and the 200 day MA is 115.52. The company has a market cap of $22,912m. You can visit the company''s website by visiting: https://www.zimmerbiomet.com [stock_market_widget type="chart" template="basic" color="green" assets="ZBH" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $26,730m based on the market concensus. Zimmer Biomet Holdings, together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.


Source:DirectorsTalk
Bioresorbable Implants Market Expected to Expand at a Steady 2022-2028 | Bioretec Ltd., CONMED Corporation, Depuy Synthes, Stryker Corporation, Zimmer Biomet Holdings, Inc.
Oct 13, 2022 13:04pm

Bioresorbable Implants Market Research focuses on the key trends prevailing in the Global Bioresorbable Implants Industry sector. The existing Industry scenario has been studied and future projections with respect to the sector have also been investigated. Market study report


Source:OpenPR
Jefferies Starts Zimmer Biomet at Underperform
Oct 11, 2022 21:14pm

https://www.investing.com/news/pro/jefferies-starts-zimmer-biomet-at-underperform-432SI-2909908


Source:Investing.com
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2022 Financial Results
Oct 05, 2022 11:00am

WARSAW, Ind., Oct. 5, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its third quarter earnings conference call will be webcast on Wednesday, November 2, 2022 at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that…


Source:PR Newswire
Hip Replacement Implants Market | Exclusive Report on Current Scenario: TMR Study
Oct 05, 2022 09:33am

WILMINGTON, DE / ACCESSWIRE / October 5, 2022 / Transparency Market Research Inc. - The emergence of new types of implants, made from combination of various materials to offer enhanced lifespan and exceptional stability are anticipated to propel growth in the global hip replacement implants market in coming years. At present, a high number of patients suffering from arthritis opt for hip replacement surgeries. Some other key reasons for undergoing hip replacement surgery include hip fracture, as well as wear and tear of the hip. According to a recent research report, the global hip replacement implants market is anticipated to register a CAGR of 4% over the forecast period of 2021 to 2031. Hip Replacement Implants Market - Key Findings of the Report Increasing demand for Metal-on-Polyethylene Materials : Players in the global hip replacement implants market offer products and solutions manufactured using various types of bio-compatible materials. These include metal on metal, ceramic on metal, ceramic on ceramic, metal on polyethylene, and ceramic on polyethylene.


Source:Accesswire
Why arthritis is a clear and present danger, and how we can fight it
Sep 30, 2022 13:47pm

Zimmer Biomet, a pioneer in making medical devices, is joining hands with Network18 to promote awareness about arthritis and bone health.


Source:CNBC TV18